<DOC>
	<DOC>NCT01882543</DOC>
	<brief_summary>The primary objective of this study is to evaluate the effect of 6 weeks of treatment with once daily administration of AQX-1125 compared to placebo on average daily pain in subjects with interstitial cystitis/bladder pain syndrome (IC/BPS), during and after treatment, using a standardized 11-point numerical rating scale (NRS) pain score recorded by electronic diary</brief_summary>
	<brief_title>Efficacy and Safety of AQX-1125 in IC/BPS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<criteria>Be females, ≥18 and ≤75 years of age who have consistently had symptoms of bladder pain in addition to urinary urgency and/or urinary frequency for more than 12 months Have had the diagnosis of interstitial cystitis for &gt; 6 months (but pain for at least 12 months) but ≤15 years Have average daily pain score of at least 5 out of 10 on the 11point NRS pain scale in the 7 days prior to baseline Have undergone a cystoscopy and have documented visible signs of bladder bleeding, lesions or glomerulation within the last 36 months prior to baseline. Subjects if of child bearing potential, must agree to avoid pregnancy and use medically acceptable method of contraception from screening visit and throughout the study. Must be capable of voiding independently Pelvic floor pain (&gt;5 out of 10 on the 11point NRS pain scale following a pelvic pain assessment) Have a body mass index [BMI] of &lt;18 kg/m2 or &gt;39 kg/m2 Have had a urinary tract infection including bacterial cystitis within the past 30 days. Have greater than 1+ hematuria on dipstick test at screening from an unknown cause History of previous procedure(s) (augmentation cystoplasty, cystectomy, or cystolysis) that has affected bladder function</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Interstitial cystitis</keyword>
	<keyword>Bladder pain syndrome</keyword>
	<keyword>IC/BPS</keyword>
	<keyword>AQX-1125</keyword>
	<keyword>SHIP1</keyword>
</DOC>